Regulatory Updates in Brief
This article was originally published in The Gold Sheet
WHO tool enables quality procurement; FDA, EMA say focus on significance; SUPAC lets technology advance; FDA’s Christmas Eve reprieve; a new way to find FDA guidance; List of API firms sought; What it’s really like to use FDA FACTS, OASIS software.
You may also be interested in...
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.